NASDAQ:STAA STAAR Surgical (STAA) Stock Price, News & Analysis $32.47 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$32.48 +0.01 (+0.02%) As of 05/22/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About STAAR Surgical Stock (NASDAQ:STAA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get STAAR Surgical alerts:Sign Up Key Stats Today's Range$32.47▼$33.3250-Day Range$17.47▼$33.0552-Week Range$15.59▼$35.87Volume738,725 shsAverage Volume1.03 million shsMarket Capitalization$1.62 billionP/E RatioN/ADividend YieldN/APrice Target$27.81Consensus RatingHold Company Overview STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Read More STAAR Surgical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreSTAA MarketRank™: STAAR Surgical scored higher than 48% of companies evaluated by MarketBeat, and ranked 528th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingSTAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 3 buy ratings, 6 hold ratings, and 2 sell ratings.Downside RiskSTAAR Surgical has a consensus price target of $27.81, representing about 14.3% downside from its current price of $32.47.Amount of Analyst CoverageSTAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about STAAR Surgical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for STAAR Surgical are expected to grow in the coming year, from ($0.03) to $0.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STAAR Surgical is -75.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STAAR Surgical is -75.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSTAAR Surgical has a P/B Ratio of 4.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about STAAR Surgical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted22.50% of the float of STAAR Surgical has been sold short.Short Interest Ratio / Days to CoverSTAAR Surgical has a short interest ratio ("days to cover") of 9.19.Change versus previous monthShort interest in STAAR Surgical has recently decreased by 10.18%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSTAAR Surgical does not currently pay a dividend.Dividend GrowthSTAAR Surgical does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.99 News SentimentSTAAR Surgical has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for STAAR Surgical this week, compared to 6 articles on an average week.Search InterestOnly 3 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $12,266,249.00 in company stock, which represents 0.7587% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,266,249.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about STAAR Surgical's insider trading history. Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STAA Stock News Headlines5 must-read analyst questions from STAAR Surgical’s Q1 earnings callMay 21, 2026 | msn.comSTAAR Surgical Company (NASDAQ:STAA) Given Consensus Recommendation of "Hold" by BrokeragesMay 21, 2026 | americanbankingnews.com$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker. | Paradigm Press (Ad)STAAR Surgical Q1 2026: Early Signs Of A Durable TurnaroundMay 16, 2026 | seekingalpha.comSTAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lensesMay 15, 2026 | seekingalpha.comSTAAR Surgical (NASDAQ:STAA) beats expectations in strong Q1 CY2026, stock jumps 18.3%May 15, 2026 | msn.comMizuho Issues Positive Forecast for STAAR Surgical (NASDAQ:STAA) Stock PriceMay 15, 2026 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Rating Increased to Outperform at WedbushMay 15, 2026 | americanbankingnews.comSee More Headlines STAA Stock Analysis - Frequently Asked Questions How have STAA shares performed this year? STAAR Surgical's stock was trading at $23.09 on January 1st, 2026. Since then, STAA shares have increased by 40.6% and is now trading at $32.47. How were STAAR Surgical's earnings last quarter? STAAR Surgical Company (NASDAQ:STAA) posted its earnings results on Wednesday, May, 13th. The medical instruments supplier reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.05. STAAR Surgical's quarterly revenue was up 119.6% on a year-over-year basis. Read the conference call transcript. Is STAAR Surgical buying back stock? STAAR Surgical's Board of Directors approved a share buyback plan on Friday, May 16th 2025, which allows the company to repurchase $30,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.2% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its stock is undervalued. Does STAAR Surgical have any subsidiaries? STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD. Who are STAAR Surgical's major shareholders? Top institutional investors of STAAR Surgical include American Capital Management Inc. (1.76%), Dimensional Fund Advisors LP (1.65%), Principal Financial Group Inc. (0.49%) and Bank of New York Mellon Corp (0.47%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner, Arthur C Butcher and Elizabeth Yeu Lin. View institutional ownership trends. How do I buy shares of STAAR Surgical? Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of STAAR Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/13/2026Today5/24/2026Stifel 2026 Virtual Ophthalmology Forum5/26/2026Status update5/27/2026Next Earnings (Estimated)8/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 STAA's financial health is in the Green zone, according to TradeSmith. STAA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED/DENTAL - SUPP Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:STAA CIK718937 Webwww.staar.com Phone(626) 303-7902Fax626-303-2962Employees1,211Year Founded1982Price Target and Rating Average Price Target for STAAR Surgical$27.81 High Price Target$40.00 Low Price Target$13.00 Potential Upside/Downside-14.3%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$80.45 million Net Margins-7.24% Pretax Margin-6.74% Return on Equity3.31% Return on Assets2.55% Debt Debt-to-Equity Ratio0.09 Current Ratio5.12 Quick Ratio4.31 Sales & Book Value Annual Sales$239.44 million Price / Sales6.75 Cash FlowN/A Price / Cash FlowN/A Book Value$7.08 per share Price / Book4.59Miscellaneous Outstanding Shares49,790,000Free Float29,923,000Market Cap$1.62 billion OptionableOptionable Beta1.20 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:STAA) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Company Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
